Covalon Technologies Ltd. (“the Company”) is incorporated under the laws of
Ontario and is engaged in the business of developing, licensing, and selling
medical technologies. The Company has received regulatory approval on
numerous products and is currently generating revenue. The Company has
adopted a business model that contracts the manufacturing and distribution of
its commercialized products through partners. The Company generates its
revenues through development contracts, licensing agreements, and distribution
contracts and sales. The Company is listed on the TSX Venture Exchange, having
the symbol COV.
There are currently no events scheduled.
|Data provided by Nasdaq. Minimum 15 minutes delayed.|